Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
185.6 GBX | -1.80% | +3.69% | -26.00% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 02 | Deutsche Bank likes TP ICAP but says sell CMC | AN |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.94 for the current period. Therefore, the company is undervalued.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-26.00% | 885M | B- | ||
+15.66% | 70.77B | B+ | ||
+5.55% | 17.14B | B+ | ||
+12.75% | 13.82B | B- | ||
+19.55% | 13.49B | A- | ||
+15.26% | 10.06B | B- | ||
-18.44% | 7.24B | C | ||
-2.08% | 6.18B | A- | ||
+2.65% | 5.26B | B- | ||
+0.37% | 5.03B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- RWS Stock
- Ratings RWS Holdings plc